Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

Platelets are chief cells in hemostasis. Apart from their hemostatic roles, platelets are major
inflammatory effector cells that can influence both innate and adaptive immune responses …

Quantitative lymphocyte alterations are frequent in patients with cancer, and strongly impact
prognosis and survival. The development of cancers in immunosuppressed patients has …

Platelets are essential effector cells in hemostasis. Aside from their role in coagulation,
platelets are now recognized as major inflammatory cells with key roles in the innate and …

The epidemiology of cancer among HIV-infected people has evolved since the beginning of
the HIV epidemic with particularly marked changes since the introduction of modern …

Background. We examined specific causes of mortality in human immunodeficiency virus
type 1 (HIV-1)—infected patients who initiated antiretroviral therapy (ART) in Europe and …

Background The relationship between the timing of the initiation of antiretroviral therapy
(ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of …

Antiretroviral therapy has revolutionized the course of HIV infection, improving immune
function and decreasing dramatically the mortality and morbidity due to the opportunistic …

Objectives To estimate life expectancy for people with HIV undergoing treatment compared
with life expectancy in the general population and to assess the impact on life expectancy of …

Background The relative roles of immunodeficiency, HIV viral load, and combination
antiretroviral therapy (cART) in the onset of individual cancers have rarely been examined …